Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer

Clinical trial NCT07325630 · RECRUITING

Trial details

NCT number: NCT07325630
Sponsor: Zhejiang Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

IBI363 + Chemotherapy

Start date: 2025-11-03
Primary completion: 2026-05-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.